Vitruvian invests in Healthcare at Home Under the deal, Vitruvian will become a majority investor alongside Hutton Collins and other existing stakeholders. The investment, along with a £100m refinancing by Royal Bank of Scotland and HSBC, will enable Healthcare at Home to continue developing the business, which treated 150,000 patients last year. With the new investment, it is thought that the value of the business is around £200m. Mike Gordon, Healthcare at Home's chief executive, said the investment "gives us flexibility to continue to expand, innovate and deliver new patient services." Investment firm Hutton Collins, which bought Healthcare at Home in 2007, appointed UBS last year to look at strategic options for the business, which provides services such as visits by nurses. Alliance Boots was thought to have shown an interest in buying Healthcare at Home, having come close to acquiring the business in 2007 as part of a joint venture with United Drug. Hutton Collins is not thought to have taken any money out of the business and the new £100m facility is believed to be on better terms than the previous one, giving the company more flexibility.